This year truly is turning out to be an impressive one of marijuana firsts. Earlier this year, publicly traded cannabis investment company Cronos Groupbecame the first pot stock to uplist from the over-the-counter exchange to the Nasdaq. Within the next two months, GW Pharmaceuticals (NASDAQ: GWPH)could become the very first cannabinoid-based drug developer to get a therapy approved by the U.
S. Food and Drug Administration (FDA).You'll Never Guess What Jeff Sessions Just Said About Marijuana
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться